Published in Healthcare Finance, Tax and Law Weekly, September 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Quest Diagnostics Incorporated.
Report 1: Quest Diagnostics Incorporated (NYSE:DGX), the nation's leading provider of diagnostic testing, information and services, announced a new, proprietary diagnostic testing technique to help physicians diagnose genetic metabolic disorders, such as phenylketonuria (PKU) and homocystinuria. Genetic metabolic disorders can impair a child's mental and physical development. The new technique measures amino acids in blood...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly